Mutations in mouse and human patched1 (ptc1) genes are associated with birth defects and cancer. Ptc1 is a receptor for Hedgehog (Hh) signaling proteins. Hh proteins activate transcription of target genes, including ptc1, and Ptc1 represses those genes, both by regulating the activity of Gli transcription factors. We have established mammalian cell lines with reduced Ptc1 function and a lacZ reporter to investigate Hh signal transduction. Embryonic fibroblasts were derived from mice, heterozygous or homozygous for a ptc1 mutation that inserts lacZ under the control of the ptc1 promoter (ptc1-lacZ). In heterozygous ptc1 cells, ptc1-lacZ was expressed at low levels but could be induced by Sonic Hedgehog (Shh) and Gli-1. Homozygous ptc1 cells expressed high levels of ptc1-lacZ without Hh stimulation. ptc1-lacZ expression was dependent on cell density in ptc1 homozygotes and Hh-stimulated heterozygotes but was independent of density when Gli1 was used to activate ptc1-lacZ. A wild-type ptc1 transgene introduced into homozygous ptc1 cells greatly reduced ptc1-lacZ expression. Expression of either half of Ptc1 alone resulted in improper maturation of the protein and a failure to complement the ptc1 ؊/؊ cells. When co-expressed, both Ptc1 halves matured and had an activity similar to that of the intact protein. Three missense PTCH1 mutations exhibited significant functions in homozygous ptc1 cells. The missense mutants retained activity when expressed at about 10-fold lower levels and appeared as stable as wild-type Ptc1. These studies suggest that some tumors and disease phenotypes may arise from small reductions in PTCH1 activity.
The patched gene (ptc) controls cell growth and specification in the developing and postnatal tissues of many animals (reviewed in Refs. 1 and 2). The basal cell nevus syndrome (BCNS) 1 is associated with mutations in a human ptc homolog, PTCH1 (3, 4) . BCNS individuals who are PTCH1 ϩ/Ϫ have developmental malformations such as polydactlyly and spina bifida and develop a variety of tumors including basal cell carcinoma (BCC) and medulloblastoma (5) . PTCH1 mutations also arise at high frequency in sporadic BCCs (6) and medulloblastomas from normal individuals (7) (8) (9) . In human skin, PTCH1 is thought to behave as a tumor suppressor gene where tumors arise when both copies of the gene are mutated (6, 8, 9) . In mice, however, medulloblastomas can arise by haploinsufficiency of ptc1 (10, 11) .
ptc is a critical regulator of signaling by the Hh family of secreted proteins (reviewed in Refs. [12] [13] [14] . In mice, three hh homologs have been identified, of which Shh has been best characterized (15, 16) . ptc encodes a multiple transmembranedomain protein (17) (18) (19) and is a receptor for Hh proteins (20 -22) . In the absence of ligand, Ptc blocks the transcription of specific genes. In vertebrates such targets include the signaling protein BMP2 (23, 24) , the transcription factor Gli1 (25, 26) , and the ptc gene itself (19, 20, 27) . Upon reception of a Hh signal, Ptc activity is blocked, thereby relieving the inhibition of target gene transcription. Ptc accomplishes its repressive effects by somehow inactivating Smoothened (Smo), a seven transmembrane domain protein required for Hh signaling (28, 29) .
In vertebrates, the transcription of many Hh-regulated targets is controlled through the activity of the Gli genes. Gli family members encode zinc finger transcription factors (30, 31) and are homologous to Cubitus interruptus in Drosophila (32) . Gli proteins appear to mediate their effects directly. Gli consensus-binding sites have been identified in the promoter sequences of HNF3␤ (33) in mice and ptc in Drosophila (34) . Furthermore, these binding sites are required for induction by Hh ligands. Gli proteins have different effects on Hh-regulated genes. In mice, Gli1 and Gli2 are transcriptional activators, whereas Gli3 is a repressor of Hh targets (35) (36) (37) . The transcription of Gli genes is also regulated, with Shh inducing Gli1 and Gli2 and repressing Gli3 (25, 38) .
ptc1-deficient mice illustrate the role of this gene in proper development and cell division. ptc1 null mutations cause multiple abnormalities in the developing limb, gut, and nervous system and are lethal at embryonic day 9 (39, 40) . Mice heterozygous for ptc1 are viable but develop a similar spectrum of tumors as BCNS patients, including BCC-like lesions, medulloblastoma, and rhabdomyosarcoma (39 -41) . Both BCNS patients and mice heterozygous for ptc1 have generalized over-growth as seen by macrocephaly and a large body size (5, 39, 40) . A decrease in body size of mice correlates with an increase of ptc1 expression (42) .
Despite its critical role as a regulator of the Hh signals, little is known about how PTCH1 controls signaling or how PTCH1 mutations cause tumors. Numerous truncation and missense mutations in PTCH1 have been identified, and these mutations are dispersed over much of the coding sequence (reviewed in Ref. 66 ). To understand how human PTCH1 mutations alter Ptc1 function, we established a Hh-and Ptc1-responsive cell culture system. Cell lines were derived from embryonic fibroblasts from heterozygous and homozygous ptc1 mice in which part of the ptc1 gene was deleted and replaced with the lacZ gene (40) . In these cells, lacZ transcription is controlled by the endogenous ptc1 promoter (ptc1-lacZ) and is regulated by Ptc1 activity. Here we show that ptc1 Ϫ/Ϫ cells have strongly increased the transcription of Hh-regulated genes. Expression of a wild-type ptc1 transgene complemented the expression of ptc1-lacZ, but ptc1 transgenes containing PTCH1 missense mutations retained significant activity. These data suggest that small reductions of PTCH1 activity may lead to tumor formation and developmental abnormalities.
EXPERIMENTAL PROCEDURES
Cell Establishment and Maintenance-Embryonic fibroblasts were generated from ptc1 ϩ/Ϫ and ptc1 Ϫ/Ϫ embryos at embryonic day 8.5 (40) . Dissected embryos were minced, trypsinized, and individually plated on 24-well plates. Cells were grown in high glucose DMEM with 15% fetal calf serum, L-glutamine, 0.1 mM ␤-mercaptoethanol, 1ϫ non-essential amino acids (Mediatech), and 1 mM pyruvate in a humidified incubator with 5% CO 2 . The cells were genotyped by PCR as described (40) . Viral supernatants were isolated following transient transfection of Bosc 23 cells with either the MSCV retroviral plasmid alone (43) or in combination with pVPack-GP and pVPack-Eco plasmids (Stratagene) to increase viral titers. Transduced cells were selected for 10 -14 days in media containing 2 g/ml puromycin. Because of the tendency of confluent cells to detach from the surface, the media were not changed during the experiments.
␤-Galactosidase Activity Determination-For in situ staining, cells were grown on cover slips, fixed for 15 min in 1% glutaraldehyde in phosphate-buffered saline, and stained for 24 h at 37°C with either 0.04% (ptc1 Ϫ/Ϫ cells) or 0.16% X-gal (ptc1 ϩ/Ϫ cells). For enzymatic assays following 5-8 days of culture, cells were first plated at 2.1 ϫ 10 4 cells/cm 2 (about 30% confluent) in 35-mm dishes. Then at different time points cells were trypsinized, counted, and lysed in 0.4 ml ␤-galactosidase lysis buffer (Promega). 50 l of cell extracts were assayed after 45 min (ptc1 Ϫ/Ϫ cells) or 24 h (ptc1 ϩ/Ϫ cells) at 37°C. For enzymatic assays following 1 day of culture, cells were plated at either 2.1 ϫ 10 4 cells/cm 2 in 35-mm dishes or 8.4 ϫ 10 4 cells/cm 2 (about 100% confluent) in 24-well plates, and 24 h later they were trypsinized, resuspended in 0.25 ml of ␤-galactosidase lysis buffer, and 50 l of cell extracts were assayed for 24 h at 37°C. ␤-galactosidase activity was calculated by (OD420)/(g of protein) (extinction coefficient of 2 ϫ 10 4 ) and was normalized to total cellular protein using Bio-Rad protein assay reagent. For each time point, duplicate wells were plated, and each well was assayed in triplicate. Values shown are averages of these six values with the associated experimental error.
Shh Induction-To make conditioned media, Bosc 23 cells were transfected with either Shh-N (44) or a control vector, and after 60 h the supernatants were isolated and filtered through a 0.45-m filter. To induce ptc-lacZ, cells were plated at 8.4 ϫ 10 4 cells/cm 2 , the media was replaced 2 h later with control or Shh-N supernatants, and the cells were assayed 48 h later.
Vectors-A hemagglutinin (HA) epitope was incorporated at the Cterminal of a mouse ptc1 cDNA (19) using PCR, then restriction-digested to remove part of the epitope including the stop codon, and ligated in-frame into a vector containing a C-terminal triple HA epitope (a gift from D. Kingsley). This tagged form of Ptc was detected by anti-HA antibodies and was fully functional. Full-length cDNAs for mouse ptc1, human Gli1 (30) , and mouse Shh (15) were cloned into MSCV-pac (45) . MSCV-IRES-enhanced GFP (a gift from C. Klug) was modified by cloning pGK-puromycin from MSCV-pac distal to IRES-GFP. All ptc1 constructs were cloned proximal to IRES-GFP. Sitedirected mutants of ptc1 were made using QuikChange™ (Stratagene), and two independent clones were analyzed for each mutant. To produce the N-and C-terminal halves of mouse ptc1, full-length ptc1 was digested with BglII. The N-terminal half was ligated in-frame into a vector containing a C-terminal triple HA epitope, and the C-terminal half was ligated in-frame in a vector containing an N-terminal triple HA epitope (a gift from D. Kingsley). The ptc1 halves were then separately cloned into MSCV.
mRNA Analysis-ptc1 ϩ/Ϫ and ptc1 Ϫ/Ϫ cells were plated at 6.7 ϫ 10 3 cells/cm 2 in 225 cm 2 flasks. After 7.5 days, ␤-galactosidase levels were measured, and total RNA was isolated using acid-guanidinium (46) . Poly(A) mRNA was isolated from total RNA using PolyATract (Promega). lacZ mRNA was detected using 10 g of total RNA, whereas all other transcripts were detected using 1 g of poly(A) mRNA. Fulllength mouse cDNA probes were used unless otherwise stated: ptc1 (19) , smo (22) , lacZ (47) , Hip (48) , Shh (15), 1.7 kb of Gli1, 1.0 kb of Gli2, 0.8 kb of Gli3 (49), 0.6 kb of ptc2 (a gift of C.C. Hui), and a 0.9-kb ␤-actin probe amplified from mouse genomic DNA with the following primers: CATTGCTCGAGGTGACGAGGCCCAGAGCAAGAG and CAAGT-CTCGAGAGGGGCCGGACTCATCGTACTC.
Immunoblot and Glycosidase Treatment-Cells were lysed in RIPA buffer with Complete protease inhibitors (Roche) for 45 min on ice. For glycosidase treatment, Nonidet P-40 was added to the lysates to a 1.5% final concentration and then incubated for 45 min at 37°C with either 1000 units of Endo H f or 500 units of PNGase F (New England Biolabs) in a 50-l volume. Lysates were solubilized in an equal volume of 2ϫ Laemmeli buffer at room temperature, size-fractionated on 7.5% polyacrylamide gels, and transferred to Protran (Schleicher & Schuell). The transfers were incubated with HA.11 (Convance), GM130 (Transduction Laboratories), or actin (Sigma) antibodies and visualized using ECL reagent (Amersham Biosciences).
Fluorescence-activated Cell Sorting (FACS) Analysis-Cells were sorted on a FACSVantage SE (BD Pharmingen), and spectra were collected and analyzed using Cell Quest, version 3.2. At least 1 ϫ 10 5 cells were isolated for each GFP level and were cultured for analysis. After sorting, cells were maintained in media containing 100 IU/ml penicillin, 100 g/ml streptomycin, and 1 mg/ml amphotericin B. Each cell line was analyzed by FACS before and after the complementation assays to ensure that the GFP distribution remained unchanged during the course of the experiment.
Metabolic 35 S LABEL, ICN) in DMEMϪcys/met for 75 min. Cells were washed once and incubated in normal medium for varying times. For brefeldin A treatment, cells were incubated with 20 g/ml brefeldin A (Sigma) during both the starvation and label period.
At each time point, cells were washed with phosphate-buffered saline, scraped into PBS plus Complete, washed again, and lysed in 0.7 ml of RIPA plus Complete for 15 min on ice. At 4°C, the extracts were pelleted at 16,000 ϫ g, and the supernatant was precleared with 50 l of Pansorbin (Calbiochem) for 10 min and immunoprecipitated for 1 h with 5 g of mouse anti-HA (Convance) or an isotype-matched control antibody. 30 l of protein-G agarose (Roche) was added for 30 min, and the immunoprecipitates were washed twice each with RIPA plus 5% bovine serum albumin and Complete, RIPA plus 500 mM NaCl, and RIPA. The immunoprecipitates were solubilized in 20 l of 2ϫ Laemmeli buffer, heated at 37°C for 5 min, and resolved on an 8% polyacrylamide gel. Gels were fixed, dried, and exposed to a phosphorimager screen (Amersham Biosciences). Decay curves were calculated using ImageQuant (Amersham Biosciences). Experiments were performed three times for wild-type Ptc1 and G495V and twice for all other constructs.
RESULTS

Isolation of ptc1
ϩ/Ϫ and ptc1 Ϫ/Ϫ Cells-Cell lines were derived from mice in which part of the ptc1 gene was deleted and replaced with a lacZ gene (ptc1-lacZ) (40) . As a result, Ptc1 function is eliminated and lacZ is placed under the control of the endogenous ptc1 promoter. In these mice, the expression pattern of ptc1-lacZ, as determined by ␤-galactosidase staining, reflects endogenous ptc1 transcription (40) . In heterozygous mice, Ptc1 inhibits ptc1-lacZ transcription except in areas adjacent to sources of Hh where inactivation of Ptc1 by Hh permits ␤-galactosidase accumulation. Homozygous null ptc1 mice die at embryonic day 9. At this stage, the absence of Ptc1 function allows persistent Hh target gene transcription, and ␤-galactosidase staining is detected in all tissues except the endoderm (40) . Heterozygous and homozygous ptc1 cells were obtained from a single litter of embryos from interbred heterozygous ptc1 mice. The cells were genotyped by PCR for the presence of the neomycin transgene and for the presence or absence of the wild-type allele of ptc1 (Fig. 1A) . ptc1 ϩ/Ϫ Cells Respond to Shh and Gli1-In heterozygous ptc1 cells, Ptc1 inhibits the transcription of Hh-activated genes (40) . Stimulation of this pathway, either by ligand inactivation of Ptc1 or overexpression of Gli1, should induce ptc1-lacZ transcription in these cells. To test this idea, we expressed Shh or Gli1 under the control of a retroviral LTR using the MSCV retrovirus (45) . ptc1 ϩ/Ϫ cells were infected with MSCV, MSCVShh (Shh cells), or MSCV-Gli1 (Gli1 cells), and stable integrants were selected for resistance to puromycin. Cells were plated at low density (ϳ30% confluence), and ␤-galactosidase enzymatic activity was determined over a course of 7 days (Fig. 1B) .
Gli1 expression immediately induced ptc1-lacZ in the heterozygous ptc1 cells even prior to plating (data not shown), whereas the response by Shh was slower and less robust. After the first day of plating, the Gli1 cells had approximately 6ϫ the ␤-galactosidase activity of the MSCV and Shh cells (Fig. 1B) . By day five, the Shh cells began to accumulate ␤-galactosidase activity, and by day seven, the Shh and Gli1 cells had 2 and 4ϫ higher levels of ptc1-lacZ, respectively, than the MSCV cells. Shh and Gli1 cells grew to twice the density of the MCSV cells, suggesting that pathway activation leads to increased cell division. After reaching their highest density, however, all three types of cells suffered similar declines in cell number (Fig. 1C) . Stimulation of signaling by a constitutively active form of ϩ/Ϫ cells, ptc1 Ϫ/Ϫ cells lack functional Ptc1 and should transcribe ptc1-lacZ in the absence of Shh. We compared ptc1-lacZ expression in the ptc1 ϩ/Ϫ and ptc1 Ϫ/Ϫ cells by plating cells at low density and assaying enzymatic activity over 8 days. Both cell types had little enzymatic activity during the first 2 days. However, by day three the cells reached confluence, and ␤-galactosidase activity increased in the ptc1 Ϫ/Ϫ cells (Fig. 2 , A-C). Eight days after plating, the ptc1 Ϫ/Ϫ cells showed a 40-fold increase over the ptc1 ϩ/Ϫ cells (Fig. 2B ). Histochemical staining of fixed cells showed that after 7 days of plating, all ptc1 Ϫ/Ϫ cells were lacZ-positive, whereas all ptc1 ϩ/Ϫ cells were negative ( Fig. 2A ). The homozygous ptc1 cells differed from stimulated heterozygous ptc1 cells in two ways: they expressed ptc1-lacZ at much higher levels and remained viable after reaching confluence. After a week of growth, the ptc1 Ϫ/Ϫ cells had 28-and 19-fold higher enzymatic activity than similarly plated ptc1 ϩ/Ϫ cells expressing either Shh or Gli1, respectively (data not shown). With respect to confluence, the density of the ptc1 Ϫ/Ϫ cells continued to increase even after reaching confluence (Fig.  2C) , whereas the ptc1 ϩ/Ϫ cells decreased in number, irrespective of Shh or Gli1 expression (Figs. 1C and 2C ). The homozygous ptc1 cells grew to even higher densities if the culture medium were replenished after confluence, whereas the heterozygous ptc1 cells did not (data not shown). This suggests that the ptc1 Ϫ/Ϫ cells are not contact-inhibited. Shh-expressing ptc1 ϩ/Ϫ constitutively express Shh and should respond by always expressing ptc1-lacZ, as should ptc1 Ϫ/Ϫ cells, which lack Ptc1 activity. However, both ptc1
and Shh-stimulated ptc1 ϩ/Ϫ cells required an additional condition, culturing at high density, before they expressed ptc1-lacZ. In contrast, ptc1 ϩ/Ϫ cells that expressed Gli1 induced ptc1-lacZ at low densities (Fig. 1, B and C) . The ability of Gli1 to induce a Hh target gene in subconfluent ptc1 heterozygous cells prompted us to see if Gli1 would have the same effect in ptc1 null cells. Both ptc1 ϩ/Ϫ and ptc1 Ϫ/Ϫ cells were stably infected with either MSCV or MSCV-Gli1 retrovirus and assayed for ptc1-lacZ activity after 24 h of culture at low cell densities. Under these conditions, the ptc1 ϩ/Ϫ and ptc1 Ϫ/Ϫ cells infected with MSCV alone had low levels of activity, whereas both cell types transduced with Gli1 had ϳ4-fold higher levels (Fig. 3) . Hence, in both heterozygous and homozygous ptc1 cells, Gli-1 can bypass the need for high densities to induce ptc1-lacZ expression.
Transcriptional Regulation of Hh Components in ptc1
ϩ/Ϫ and ptc1 Ϫ/Ϫ Cells-In the ptc1 Ϫ/Ϫ cells, the increase in ␤-galactosidase activity over time could be caused by the accumulation of ptc1-lacZ transcripts or by increased translation of previously transcribed mRNA. To distinguish between these possibilities, we examined ptc1-lacZ expression in ptc1 Ϫ/Ϫ and ptc1 ϩ/Ϫ cells that were cultured at high density (ϳ100% confluence) for either 12 h or 6 days. The ptc1-lacZ transcript could not be detected in the ptc1 ϩ/Ϫ cells isolated at either time point. In the ptc1 Ϫ/Ϫ cells, a 4-kb transcript present at low levels initially was induced about 10-fold on day six (Fig. 4A) . The blot was subsequently probed with ␤-actin (Fig. 4A ) and glyceraldehyde-3-phosphate dehydrogenase (data not shown), and both transcripts decreased after 6 days in both cell types. Transcripts for two other Hh pathway components, CREB-binding protein (CBP) and smo, were unchanged by culturing at high density in both cell types (data not shown). These data indicate that the induction of ptc1-lacZ in homozygous ptc1 cells in response to culturing at high density is specific and not a general transcriptional property in these cells.
The transcriptional regulation of other Hh signaling components was examined in ptc1 Ϫ/Ϫ and ptc1 ϩ/Ϫ cells. Cells were cultured for 7.5 days and used as a source of mRNA to determine the expression of Shh, smo, and the three Gli genes (Fig.  4B) . Neither the ptc1 ϩ/Ϫ nor ptc1 Ϫ/Ϫ cells expressed Shh (data not shown), but both expressed similar levels of smo. Gli1 and Gli2 were expressed in the ptc1 Ϫ/Ϫ cells, but only Gli2 was detected in the ptc1 ϩ/Ϫ cells, at about 4-fold lower levels. Gli3 was regulated in the opposite manner, with 3-fold lower expression in the ptc1 Ϫ/Ϫ cells compared with the ptc1 ϩ/Ϫ cells. The Hh receptors, Hip (48) and ptc2 (51) (52) (53) , were detectable in the ptc1 Ϫ/Ϫ cells but not in the ptc1 ϩ/Ϫ cells (Fig. 4B) . However, ptc2 expression was detected in the ptc1 ϩ/Ϫ cells by RT-PCR, suggesting that this mRNA is present at very low levels (data not shown). These Shh targets are regulated in the ptc1 cells like they are in vivo, indicating that multiple aspects of Hh signaling are reproduced in this cell culture model.
Complementation of the ptc1 Ϫ/Ϫ Cells by a ptc1 Transgene-To test whether a ptc1 transgene can reduce the high levels of ptc1-lacZ in the ptc1 Ϫ/Ϫ cells, mouse Ptc1 containing an HA epitope at the C-terminal was expressed using the MSCV retrovirus. ptc1 Ϫ/Ϫ cells were infected with either MSCV (MSCV cells) or MSCV-ptc1 (Ptc1 cells), plated at high density for 24 h, and assayed for ␤-galactosidase activity. These conditions considerably shortened the length of time required to assay ptc1-lacZ activity and yielded results comparable with those from longer culture times. Following 24 h of culture, the MSCV cells had high levels of ␤-galactosidase activity, whereas the Ptc1 cells had about 7-fold lower levels (Fig. 5A) . The HA epitope did not appear to alter Ptc1 function as both a tagged and an untagged version complemented the ptc1 Ϫ/Ϫ cells equally well (data not shown). Although ptc1-lacZ expression was largely complemented in this assay, the ␤-galactosidase levels were not quite as low as in similarly plated ptc1 ϩ/Ϫ cells (data not shown).
The complemented ptc1 Ϫ/Ϫ cells responded to Shh by inducing ptc1-lacZ. The MSCV and Ptc1 cells were grown for 2 days in control or Shh-containing conditioned media and assayed for ␤-galactosidase activity. Although neither condition altered ␤-galactosidase levels in the MSCV cells, Shh treatment of the Ptc1 cells induced ␤-galactosidase activity to a level comparable with the MSCV cells (Fig. 5B) . These experiments indicate that the ptc1 transgene is fully functional because it inhibits ptc1-lacZ transcription and reactivates this target gene in response to ligand.
Both Halves of Ptc1 Are Required for Ptc1 Function-In Drosophila, expression of either the N-terminal or C-terminal half of Ptc alone results in no activity, whereas co-expression of both largely reconstitutes function (54) . A number of PTCH1 mutations found in human tumors are predicted to produce truncated proteins similar to the N-terminal half of fly Ptc (55) (56) (57) . To understand the effect of these human mutations, we tested whether the two halves of mouse Ptc1 had activity when expressed alone or together in ptc1 Ϫ/Ϫ cells. Homozygous ptc1 cells were stably infected with a retrovirus expressing an HA-tagged N-terminal (Ptc1-N) or C-terminal half of Ptc1 (Ptc1-C). Immunoblots of total cell extracts indicated that Ptc1-N and Ptc1-C migrated as doublets of ϳ90 and 100 kDa, respectively, about 10% larger than their predicted sizes of 80 and 90 kDa, respectively (Fig. 6A ). The steady-state level of Ptc1-C was ϳ5-fold higher than that of Ptc1-N when compared Ϫ/Ϫ cells (solid bars) infected with MSCV had relatively low ␤-galactosidase activity, whereas infection with Gli1 increased levels. Numbers beneath bars indicate fold levels relative to MSCV cells.
FIG. 4. Regulation of Hh target genes in ptc1 heterozygous and null cells. A, ptc1
Ϫ/Ϫ but not ptc1 ϩ/Ϫ cells induced ptc1-lacZ transcription after culturing at high densities. B, although both ptc1 ϩ/Ϫ and ptc1 Ϫ/Ϫ cells expressed smo, the ptc1 Ϫ/Ϫ cells induced Gli1, Gli2, Hip, and ptc2 and repressed Gli3 relative to ptc1 ϩ/Ϫ cells. Gli1, Hip, and ptc2 expression were not detected in the ptc1 ϩ/Ϫ cells.
with actin levels that were used as a control for sample loading. Either half of Ptc1 alone had no function in the ptc1 Ϫ/Ϫ cells because ␤-galactosidase levels were similar to the MSCV control (Fig. 6B) .
Co-expression of the Ptc1 halves reconstituted function almost as well as the intact protein. To express both halves, the Ptc1-N cells were superinfected with the Ptc1-C retrovirus to generate Ptc1-NϩC cells. Although either Ptcl half alone was nonfunctional, co-expression of both reduced ␤-galactosidase levels by 3-fold (Fig. 6B ). When treated with Shh supernatants, both Ptc1 and Ptc1-NϩC cells responded similarly with a marked increase in ␤-galactosidase activity (data not shown). These results indicate that mouse Ptc1 requires both halves for activity and that the halves can function even when produced as two separate proteins.
Both Halves of Ptc1 Are Required for Ptc1 Maturation-Coexpression of both Ptc1 halves resulted in higher molecularweight proteins than when either half was expressed alone (Fig. 6A) . Because Ptc1 is a glycoprotein (58), we examined whether either half was glycosylated. When treated with either PNGase F (data not shown) or endoglycosidase H (Endo H), the mobility of both Ptc1-N and Ptc1-C increased, so they migrated near their predicted sizes (Fig. 6C) . Both halves, therefore, contain N-linked glycosylation sites. Glycoproteins in the endoplasmic reticulum and cis-Golgi are Endo H-sensitive, but upon entering the medial Golgi the carbohydrates are modified into an Endo H-resistant form (59) . Although both Ptc1-N and Ptc1-C were completely Endo H-sensitive when expressed separately, the halves were partially Endo H-resistant when expressed together (Fig. 6C ). This suggests that both halves of Ptc1 are required for proper maturation of the protein during biosynthesis.
PTCH1 Missense Mutations Modestly Reduce Ptc1
Function-PTCH1 mutations have been proposed to inactivate the function of the protein in tumors, thereby causing inappropriate Hh signaling and excess cell division (3, 4, 6) . Indeed, numerous truncating mutations have been identified, mutations that presumably eliminate PTCH1 function (57). It is not clear, however, how missense mutations affect protein function. We tested three missense mutations in PTCH1 that were identified in either BCNS individuals or sporadic BCCs. These mutations, G509V (60), Q816L (4), and R1114W (61) are unlikely to be benign polymorphisms because they alter highly conserved residues. Furthermore, at positions 509 and 816, mutations have been identified in several independent tumors or BCNS individuals (4, 60) .
Using site-directed mutagenesis, we incorporated these mutations at the corresponding positions in mouse ptc1 (G495V, Q802L, and R1100W), cloned each into MSCV, and stably infected the ptc1 Ϫ/Ϫ cells. All three Ptc1 mutants were expressed at levels comparable with the wild-type protein (Fig. 7A) . When assayed for ␤-galactosidase activity, the mutants retained significant, though reduced, activity (Fig. 7B) . Compared with normal Ptc1, the G495V, R1100W, and Q802L mutations reduced function by 3.7-, 2.3-, and 1.8-fold, respectively.
The missense mutants may have activity in the ptc1 Ϫ/Ϫ cells because the proteins are produced at artificially high levels. Overexpression of the mutants could overcome a modest folding or structural defect and complement ptc1 Ϫ/Ϫ cells. To address this concern, we isolated cells that expressed lower levels of transgene-derived Ptc1. A modified MSCV retrovirus was used that expresses transgenes as a bicistronic message proximal to an IRES followed by GFP. Because the expression level of the gene proximal to the IRES correlates well with the expression level of GFP (62), cells producing low levels of Ptc1 could be purified on the basis of GFP expression using FACS.
The correlation between the level of GFP fluorescence, Ptc1 production, and the ability to complement ptc1 Ϫ/Ϫ cells was first analyzed for the wild-type protein. ptc1 Ϫ/Ϫ cells were stably infected with Ptc1 IRES-GFP (Fig. 8, A and B) , and cells expressing high or low levels of GFP were isolated by FACS (Fig. 8A) . When grown in culture, both sets of cells stably Ϫ/Ϫ cells infected with control (MSCV), Ptc1-N (N), Ptc1-C (C), or both Ptc1-N ϩ Ptc1-C (NϩC) retrovirus were tested for protein production (A), ␤-galactosidase activity (B), and sensitivity to Endo H (C). B, when expressed separately in the ptc1 Ϫ/Ϫ cells, Ptc1-N or Ptc1-C was not functional, whereas co-expression of both halves reconstituted Ptc1 activity to a level similar to the intact protein.
Numbers beneath bars indicate fold levels relative to Ptc1 cells. C, when treated in the absence (-) or presence (ϩ) of Endo H, Ptc1-N or Ptc1-C glycosylation was Endo H-sensitive when expressed separately but partially resistant when co-expressed. Actin was a loading control for the immunoblots. maintained their GFP expression levels over time as determined by FACS (data not shown). The Ptc1 IRES-GFP cells had about 8ϫ less ␤-galactosidase activity than the unsorted IRES-GFP control, independent of whether they expressed high or low levels of GFP (Fig. 8B) . The 3.5-fold difference in GFP fluorescence between the high and low populations corresponded to a similar difference in Ptc1 protein as detected by immunoblot (Fig. 8C) . Hence, over the range tested, the level of complementation was independent of the amount of Ptc1 produced. Both high and low levels of Ptc1 functioned equally well.
The Ptc1 missense mutants were cloned into the bicistronic MSCV retrovirus, and for each low, and high GFP-expressing populations were isolated by FACS. The mean fluorescence intensity for the high GFP-expressing populations for all constructs was about 7-10-fold the mean fluorescence of the low expressing populations (data not shown). An immunoblot of cell lysates confirmed the correlation between GFP fluorescence and Ptc1 protein levels (Fig. 9A) . Both wild-type and Q802L Ptc1 reduced ␤-galactosidase activity by 10 -12-fold at both high and low expression levels (Fig. 9B) . When selected for high expression, R1100W and G495V reduced ␤-galactosidase activity by about 7-fold (Fig. 9B) , similar to that seen with unselected populations (Fig. 8B) . However, when selected for low expression, G495V, but not R1100W, had further reduced activity; ␤-galactosidase levels were lowered only 4-fold. Thus, even with an approximate 10-fold reduction in protein production, all three mutants retained most or all of their activity.
The Stability of PTCH1 Mutants Is Not Substantially Altered-To determine whether the reduced activity of the Ptc1 mutants was from decreased protein stability, we measured the half-life of wild-type Ptc1 and each of the missense mutants. ptc1 Ϫ/Ϫ cells expressing wild-type or mutant Ptc1 were sorted for high levels of GFP fluorescence and grown in culture. Cells were metabolically labeled with 35 S-containing amino acids and then incubated with excess unlabelled amino acids for various lengths of time. Ptc1 proteins were immunoprecipitated and size-separated by SDS-PAGE. Cells expressing wildtype Ptc1 were also treated with brefeldin A during the pulse period to induce a block in endoplasmic reticulum to Golgi trafficking (63) . The mobility of Ptc1 under this condition indicates the mobility of the newly synthesized, immature form of Ptc1 (Fig. 10A, arrowhead) . The immature form of Ptc1, with an apparent molecular mass of ϳ170 kDa, is only faintly visible in the absence of brefeldin A (BFA). Glycosylation of Ptc1 during maturation causes the protein to migrate diffusely in the range of 175-185 kDa (Fig. 10A, bracket) . Wild-type Ptc1 had a half-life of 42 Ϯ 6.7 min. The half-lives for G495V, R1100W, and Q802L were 43 Ϯ 20 min, 64 Ϯ 9.9 min, and 25 Ϯ 2.6 min, respectively. Because these half-lives were within a factor of two of that of wild-type Ptc1, it appears that the missense mutations do not substantially alter the stability of the protein. Ϫ/Ϫ cells expressing missense mutations G495V, R1100W, or Q802L were examined for transgene production (A) and regulation of ptc1-lacZ activity (B). A, even though the missense mutants were produced at levels comparable with the normal protein (B), R1100W-and G495V-expressing cells had 2-4-fold higher ␤-galactosidase activity as cells expressing wild-type Ptc1.
FIG. 8. Isolation and characterization of ptc1
؊/؊ cells expressing high or low levels of Ptc1. A heterogeneous population of ptc1 Ϫ/Ϫ cells expressing Ptc1 IRES-GFP were sorted for high or low GFP by FACS (A) and assayed for ptc1-lacZ activity (B) and Ptc1 protein (C). A, FACS analysis of uninfected ptc1 Ϫ/Ϫ cells showed very low fluorescence (top left), whereas cells infected with a control IRES-GFP retrovirus had a broad distribution (top right). Cells expressing high and low GFP were sorted, grown, and when analyzed again by FACS, maintained stable GFP levels during culture (lower panels). B, Ptc1 IRES-GFP-infected cells sorted for high or low GFP fluorescence had about 8-fold less ␤-gal activity compared with unsorted MSCV control cells and (C) showed correspondingly high or low Ptc1 protein expression as detected by immunoblot.
DISCUSSION
lacZ Is an Endogenous Reporter for Hh Signaling-We have used a lacZ gene inserted into a Hh target gene to study the activities of Hh pathway components. ptc1-lacZ is a sensitive and specific indicator of Hh signaling and offers several unique advantages. Since ptc1-lacZ is present in cells in one or two copies, this avoids problems caused by high copy reporter plasmids such as titering out limiting transcription factors (squelching). Although most Hh-regulated target genes are induced in only a subset of responsive tissues, almost all developing cells that can or do respond to Hh signals include ptc1 induction in the response (40) . Hence ptc1-lacZ is a faithful indicator of signal transduction by the Hh pathway. In addition to ptc1-lacZ, other Shh targets, such as Hip, ptc2, Gli1, Gli2, and Gli3, are appropriately modulated in the ptc1 ϩ/Ϫ and ptc1 Ϫ/Ϫ cells.
High Densities Are Required for Induction of ptc1-lacZ-
According to current models of Hh signaling, both ptc1 Ϫ/Ϫ cells and Shh-stimulated ptc1 ϩ/Ϫ cells should persistently express ptc1-lacZ. However, neither expresses ptc1-lacZ until they have been cultured at high density (Figs. 1B and 2B and Ref. 64) . The density-dependence of Hh signaling has also been observed in NIH-3T3 cells (64) . Culturing at high density appears to be permissive rather than instructive because in the absence of other stimuli, high density alone does not induce ptc1-lacZ in the ptc1 heterozygous cells (Fig. 2A) . The densitydependence does not appear to be caused by the accumulation or depletion of a factor in the culture medium because exposure of cells to conditioned media from confluent ptc1 Ϫ/Ϫ cells does not induce ptc1-lacZ in subconfluent ptc1 Ϫ/Ϫ cells (data not shown). High densities may cause the induction of a component required for Hh signal transduction. smo and CBP are not such targets, because their expression is not modulated by changes in cell-density in either the ptc1 ϩ/Ϫ or ptc1 Ϫ/Ϫ cells (data not shown).
The density requirement of both heterozygous and homozygous ptc1 cells can be bypassed by Gli1 expression. Gli1 may be limiting in cells plated at low density, and the effect of culturing at high densities may be to induce Gli1, after which ptc1 and other genes regulated by Hh are transcriptionally activated. Interestingly, ptc1 ϩ/Ϫ cells expressing Gli1 had a further 2-fold increase in ␤-galactosidase levels after being cultured at high densities (Fig. 1B) . Hence, expression of Gli1 does not appear to account for all of the effects of density. At present, the signals and mechanisms mediating the density-dependence of Hh signaling are not known.
The density-dependence for Hh signaling may provide insight into the low metastatic potential of BCC (5) . Metastasis requires local invasion and systemic distribution of tumor cells. Hh signaling induces expression of the anti-apoptotic gene bcl-2 in human keratinocytes and promotes growth by making these cells refractory to cell cycle inhibitors (65) . If ptc1 Ϫ/Ϫ cells require high cell densities to acquire these features, isolated metastatic cells would lose their growth and anti-apoptotic advantages once they have separated from the primary tumor focus. Such a tumor type would be more likely to spread by local expansion, consistent with the normal course for BCC.
A Requirement for Both Halves of Ptc1 for Maturation and Function-Ptc homologs from a variety of animals appear to have a duplicated structure composed of six putative transmembrane domains and a major extracellular loop in a tandem repeat (66) . These characteristics are similar to that of transporter family members and suggest that either half of Ptc alone
؊/؊ cells expressing reduced levels of mutant Ptc1 proteins still retain significant activity. ptc1
Ϫ/Ϫ cells infected with the parental IRES-GFP retrovirus (M) or wild-type (P), G495V (G), R1100W (R), or Q802L (Q). Ptc1 IRES-GFP retrovirus were sorted for high or low GFP levels and analyzed for protein expression (A) and ␤-galactosidase activity (B). A, high and low GFP-expressing cells were sorted for a 7-10-fold difference in fluorescence and showed a similar range of protein expression for each form of Ptc1 as seen by immunoblot. B, the R1100W and Q802L mutations showed similar activity at either expression level, whereas G495V had even less activity when expressed at the lowest levels. might be functional as has been tested for several transporters. In Drosophila, expression of either Ptc half alone has no function, but co-expression of both halves reconstitutes activity (54) . Similarly, neither half of mouse Ptc1 was functional in the ptc1 Ϫ/Ϫ cells. Co-expression of both halves reconstituted activity comparable with intact Ptc1 (Fig. 6B) .
Both halves of Ptc1 are required for the proper maturation of the protein during biosynthesis. When expressed alone, each half was blocked in the secretory pathway prior to the medialGolgi, as detected by Endo H sensitivity. When the two halves were co-expressed, a subpopulation became Endo H resistant and function was detected (Fig. 6, B and C ). Ptc1 appears to require self-association to fully mature and become functional. Because both halves contained an HA epitope, we could not determine what portion of the Endo H resistant population represented Ptc1-N or Ptc1-C.
Some PTCH1 Mutation Retain Significant Function-We have analyzed three missense PTCH1 mutations identified from BCNS patients or BCCs. In addition we have tested Ptc1-N, a deletion that is similar to a number of truncating mutations found in sporadic tumors or BCNS patients (55) (56) (57) . With the exception of Ptc1-N and Ptc1-C, the other Ptc1 mutants had some activity in ptc1 Ϫ/Ϫ cells. The Q802L mutant worked as well as the wild-type protein, whereas the G495V and R1100W mutants had 2 to 4-fold reduced activity. Why these mutations retain significant function could be explained in several ways.
One possibility is that the mutations are benign polymorphisms rather than functionally significant alterations. Several observations make this unlikely. Sequence alignments show that mouse Ptc1 residues Q802 and G495 are identical, and R1100 is highly conserved among 12 Ptc1 and Ptc2 homologs (data not shown), arguing that these residues are functionally important. Additionally, mutations at residues G509 and Q816 of human PTCH1 have each been found in multiple BCNS or BCC patients (4, 60, 67) . For these reasons these changes are unlikely to be benign polymorphisms.
The Ptc1 mutants may show substantial activity in the ptc1 Ϫ/Ϫ cells because they are probably produced at artificially high levels by the retrovirus. It is possible that expression of the mutants at levels like that of endogenous Ptc1 may reveal profound functional defects. Because of the lack of high affinity Ptc1 antibodies, it has not been possible for us to detect endogenous Ptc1 in either unstimulated or Shh-stimulated cells. Thus we do not know how the expression levels of transgenederived Ptc1 compare with the endogenous protein. However, wild-type Ptc1 can largely complement the ptc1 Ϫ/Ϫ cells at levels barely detectable by immunoblot (data not shown), suggesting that the retrovirus overexpresses Ptc1 transgenes many fold over what is required for complementation. To address the issue of overexpression, we isolated ptc1 Ϫ/Ϫ cells that produced lower amounts of exogenous Ptc1 using a retrovirus that coupled transgene expression with GFP production via an IRES. Cells containing high or low levels of GFP were isolated by FACS and contained correspondingly high or low levels of Ptc1 (Fig. 8C) , similar to that observed with other transgenes (62) . For the missense mutants, cells were isolated that contained 7-to 10-fold differences in GFP levels. In only G495V was activity titrated by lowering expression levels. Q802L had near wild-type function and R1100W had twice the ␤-galactosidase levels compared with the normal protein, irrespective of its expression level (Fig. 9, A and B) . These results suggest, contrary to our initial expectations, that PTCH1 missense mutants are compromised but not devoid of function.
The partial loss of activity of the PTCH1 mutants could be due to destabilization of the protein. We performed metabolic labeling experiments to measure the half-lives of wild-type and mutant Ptc1 proteins. As measured in the ptc1 Ϫ/Ϫ cells, normal Ptc1 was degraded rapidly, with a half-life of about 40 min. For comparison, the immature form of the transmembrane protein cystic fibrosis transmembrane conductance regulator (CFTR) is similarly unstable, with an initial half-life of 20 -40 min. Within 60 min, a portion of CFTR acquires a mature conformation, after which it has an ϳ20-fold increase in stability (68, 69) . Ptc1, however, does not acquire a more stable conformation but appears to be degraded with a half-life similar to that of immature CFTR. The Ptc1 missense mutants were degraded with similar kinetics, each with half-lives that were within a factor of two of wild-type Ptc1. Because of the difficulty of accurately measuring such brief half lives, we believe that a 2-fold difference in turnover is not significantly different. However, we cannot rule out subtle differences in half-life between the missense mutants and the normal protein. Overall, we believe that these missense mutations do not alter Ptc1 stability, consistent with their retention of significant function in the ptc1 Ϫ/Ϫ cells. Environmental and genetic factors in conjunction with PTCH1 mutations contribute to the severity of clinical features in BCNS families (5, 57, 70) . Given these extragenic influences, it is still reasonable to expect different BCNS phenotypes to correlate with the type of Ptc1 mutation, similar to what has been seen with other tumor suppressors (71, 72) . Previous work (57) has not revealed a phenotype-genotype correlation between PTCH1 mutations and the spectrum of anomalies in BCNS patients; however, this study only analyzed truncating mutations. Recent analysis of a similar series of truncating mutations in Drosophila revealed that most Ptc truncations have no activity (73) . In this report, we have analyzed a truncating mutation (Ptc1-N) and missense mutations. Our finding of a spectrum of activity in these PTCH1 mutants, and the presence of activity in all the missense mutants, may merit an extension of the earlier study of phenotype-genotype correlations to include missense alterations. It is possible that PTCH1 truncation mutations may have little or no activity and might correlate with more severe presentations, whereas mutations that alter single amino acids may retain activity and associate with milder clinical outcomes.
It seems likely that even slight reductions in Ptc1 activity may cause inappropriate Hh target gene activity and tumor formation. In mice, medulloblastomas and certain developmental defects arise from ptc1 haploinsufficiency (10, 11) . Some developmental defects in BCNS patients also arise from loss of a single copy of PTCH1 (5) . The ptc1 Ϫ/Ϫ cells provide a useful system for analyzing the effects of tumor-derived mutations in PTCH1 and for studying other steps in Hh signal transduction.
